Cited by — Revisiting AXL as a therapeutic target in soft tissue sarcoma: dubermatinib and bemcentinib effects are largely independent of AXL inhibition | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Revisiting AXL as a therapeutic target in soft tissue sarcoma: dubermatinib and bemcentinib effects are largely independent of AXL inhibition.
No admitted local citation edges point to this work yet.
